"The landmark results of the IMPACT trial suggest a window of opportunity in early childhood to induce remission of peanut allergy through oral immunotherapy."
Two studies being presented at the ACAAI Annual Scientific Meeting contain new information on how prenatal diet, how the baby is delivered, and infant feeding practices can affect the risk of allergy.